These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8905223)

  • 21. Hyperhomocysteinemia and protein damage in chronic renal failure and kidney transplant pediatric patients--Italian initiative on uremic hyperhomocysteinemia (IIUH).
    Perna AF; Ingrosso D; Molino D; Galletti P; Montini G; Zacchello G; Bellantuono R; Caringella A; Fede C; Chimenz R; De Santo NG
    J Nephrol; 2003; 16(4):516-21. PubMed ID: 14696753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of visual evoked potentials in chronic renal failure patients with different treatment modalities.
    Seymen P; Selamet U; Aytac E; Trabulus S; Seymen HO
    J Nephrol; 2010; 23(6):705-10. PubMed ID: 20301086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of life of patients having renal replacement therapy.
    Niu SF; Li IC
    J Adv Nurs; 2005 Jul; 51(1):15-21. PubMed ID: 15941456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
    Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kidney damage after renal ablation is worsened in endothelial nitric oxide synthase -/- mice and improved by combined administration of L-arginine and antioxidants.
    Mendoza MG; Castillo-Henkel C; Medina-Santillan R; Jarillo Luna RA; Robles HV; Romo E; Rios A; Escalante B
    Nephrology (Carlton); 2008 Jun; 13(3):218-27. PubMed ID: 18315704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dementia and depression in end stage renal disease: comparison between hemodialysis and continuous ambulatory peritoneal dialysis.
    Sithinamsuwan P; Niyasom S; Nidhinandana S; Supasyndh O
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S141-7. PubMed ID: 16858952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis.
    Chuang CK; Lin SP; Chen HH; Chen YC; Wang TJ; Shieh WH; Wu CJ
    Clin Chim Acta; 2006 Feb; 364(1-2):209-16. PubMed ID: 16087168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-18 is involved in vascular injury in end-stage renal disease patients.
    Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
    Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current trends in dialysis therapy.
    Jacobs C
    Kidney Int Suppl; 1997 Nov; 62():S93-5. PubMed ID: 9350692
    [No Abstract]   [Full Text] [Related]  

  • 30. Does diurnal variation in blood pressure exist in CAPD patients?
    Goldsmith DJ
    Nephrol Dial Transplant; 1994; 9(11):1698-9. PubMed ID: 7870371
    [No Abstract]   [Full Text] [Related]  

  • 31. Pulmonary function in renal transplant recipients and end-stage renal disease patients undergoing maintenance dialysis.
    Karacan O; Tutal E; Colak T; Sezer S; Eyüboğlu FO; Haberal M
    Transplant Proc; 2006 Mar; 38(2):396-400. PubMed ID: 16549130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 1999; 15():60-4. PubMed ID: 10682073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative studies on the effect of sodium chloride or liquids on the blood pressure of patients under a chronic hemodialysis program].
    Liebau H; Eisenbach G; Maris P
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1546-51. PubMed ID: 1030042
    [No Abstract]   [Full Text] [Related]  

  • 34. L-arginine: a new opportunity in the management of clinical derangements in dialysis patients.
    Bellinghieri G; Santoro D; Mallamace A; Di Giorgio RM; De Luca G; Savica V
    J Ren Nutr; 2006 Jul; 16(3):245-7. PubMed ID: 16825029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The best and worst times for dialytic therapy are now.
    Friedman EA
    ASAIO J; 1994; 40(2):107-8. PubMed ID: 8003746
    [No Abstract]   [Full Text] [Related]  

  • 36. [Physical exercise and chronic renal insufficiency].
    Bolaños L; Mesa L; Vázquez C; Lavilla J; Errasti P
    Rev Med Univ Navarra; 1993; 38(1):38-41. PubMed ID: 8711308
    [No Abstract]   [Full Text] [Related]  

  • 37. The unsuitability of BUN as a criterion for prescription dialysis.
    Shapiro JI; Argy WP; Rakowski TA; Chester A; Siemsen AS; Schreiner GE
    Trans Am Soc Artif Intern Organs; 1983; 29():129-34. PubMed ID: 6673221
    [No Abstract]   [Full Text] [Related]  

  • 38. Gastric emptying in patients with chronic renal failure.
    Gladziwa U; Bares R; Klotz U; Sieberth HG
    Nephrol Dial Transplant; 1994; 9(11):1694-5. PubMed ID: 7726972
    [No Abstract]   [Full Text] [Related]  

  • 39. Impact of nitric oxide on blood pressure in hemodialysis patients.
    Madore F; Prud'homme L; Austin JS; Blaise G; Francoeur M; Léveillé M; Prud'homme M; Vinay P
    Am J Kidney Dis; 1997 Nov; 30(5):665-71. PubMed ID: 9370182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Problem of thirst in patients receiving regular haemodialysis treatment [author's transl)].
    Lachmanová J; Horký K; Tomásek R; Dvoráková J
    Cas Lek Cesk; 1980 Aug; 119(33-34):902-5. PubMed ID: 7438160
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.